Skip to content

Food and Drugs Act

R.S.C., 1985, c. F-27

In forceCurrent to September 30, 2026 History

Follow

Part I — Foods, Drugs, Cosmetics and Devices

Advanced Therapeutic Products

Section 21.91

Marginal note:Additions to Schedule G

  •  (1) For the purpose of preventing injury to health or preventing a person from being deceived or misled, the Minister may, by order, add a description of a therapeutic product or a class of therapeutic products to Schedule G if the Minister believes that the therapeutic product or products represent an emerging or innovative technological, scientific or medical development.

  • Marginal note:Factors

    (2) Before adding a description of a therapeutic product or a class of therapeutic products to Schedule G, the Minister shall consider the following factors:

    • (a) the degree of uncertainty respecting the risks and benefits associated with the therapeutic product or products and the measures that are available to adequately manage and control those risks;

    • (b) the extent to which the therapeutic product or products are different from therapeutic products for which therapeutic product authorizations have been issued under the regulations;

    • (c) the extent to which existing legal frameworks are adequate to prevent injury to health or to prevent persons from being deceived or misled; and

    • (d) the prescribed factors, if any.

  • Marginal note:Deletion from Schedule G

    (3) The Minister may, by order, delete the description of a therapeutic product or a class of therapeutic products from Schedule G.

  • 2019, c. 29, s. 169
.

Version in force since June 21, 2019

Unofficial reproduction of the consolidated text published by the Department of Justice Canada, permitted by the Reproduction of Federal Law Order. Only the official text is authoritative.